The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs

A vaccine that prevents hepatitis C virus (HCV) infection is urgently needed to support an emerging global elimination program. However, vaccine development has been confounded because of HCV's high degree of antigenic variability and the preferential induction of type‐specific immune responses...

Full description

Saved in:
Bibliographic Details
Published in:Hepatology
Main Authors: Vietheer, Patricia T., Boo, Irene, Gu, Jun, McCaffrey, Kathleen, Edwards, Stirling, Owczarek, Catherine, Hardy, Matthew P., Fabri, Louis, Center, Rob J., Poumbourios, Pantelis, Drummer, Heidi E.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2017
Subjects:
Viral Hepatitis
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408392/
https://ncbi.nlm.nih.gov/pubmed/27997681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28989
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items